Important differences: Canadian Diabetes Association 2008 clinical practice guidelines and the consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

Diabetologia

Volumn 52, Issue 3, 2009, Pages 552-553

  Woo, V ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLIBENCLAMIDE; INSULIN; METFORMIN; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE;

BLOOD GLUCOSE MONITORING; CANADA; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DRUG TREATMENT FAILURE; EUROPE; GLYCEMIC CONTROL; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HYPERGLYCEMIA; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNITED STATES;

ALGORITHMS; CANADA; DIABETES MELLITUS; EUROPE; EVIDENCE-BASED MEDICINE; HUMANS; HYPOGLYCEMIC AGENTS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; UNITED STATES;

EID: 59449094308     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-008-1236-0     Document Type: Letter

References (6)

1. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee 2008 Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada Can J Diabetes 32 Suppl 1 S1 S201
2. Nathan D, Buse J, Davidson MB et al (2008) Medical management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia doi: 10.1007/s00125-008-1157-y
3. The AGREE Collaboration 2003 Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project Qual Saf Health Care 12 18 23
4. The Action to Control Cardiovascular Risk in Diabetes Study Group 2008 Effects of intensive glucose lowering in type 2 diabetes N Eng J Med 358 2545 2559
5. PD Home SJ Pocock J Beck-Nielsen 2008 Rosiglitazone evaluated for cardiovascular outcomes-an interim analysis N Eng J Med 357 28 38
6. American Diabetes Association (2008) Intense blood glucose control yields no significant effect on CVD reduction in VA Diabetes Trial. Available from http://www.diabetes.org/for-media/pr-intense-blood-glucose-control-yields-no- significant-effect-on-cvd-reduction.jsp, accessed 21 November 2008